Core Viewpoint - BrightSpring Health Services has completed the sale of ResCare Community Living to Sevita, emphasizing a commitment to continuity of care and operational stability for individuals with intellectual and developmental disabilities [1][2]. Group 1: Transaction Details - The divestiture of the Community Living business was a strategic decision aimed at ensuring high-quality care for clients, allowing both BrightSpring and Sevita to focus on their respective missions [2]. - The sale was first announced in January 2025, and the transition was conducted with a focus on care quality, regulatory continuity, and workforce stability [3]. Group 2: Company Profiles - BrightSpring Health Services provides home- and community-based pharmacy and health solutions for complex populations, serving over 450,000 customers daily across all 50 states [5]. - Sevita has over 50 years of experience in providing innovative services and individualized support, currently serving 50,000 individuals in 40 states [6].

Group 1 - Unilever PLC is reportedly in discussions to spin off its food business and combine it with McCormick in an all-stock transaction, focusing the remaining company on beauty, personal care, and home products segments [1] - McCormick has confirmed its engagement in discussions with Unilever regarding a potential strategic transaction involving the food business, but there is no certainty that a deal will be reached [2] - Unilever has been exploring options to streamline its portfolio, including a potential separation of its food business, and is working with advisers in the early stages of evaluating alternatives [4]

Core Insights - Ashland Inc. (ASH) has implemented pricing actions across its product portfolios in response to volatility in energy markets, raw material costs, and logistics challenges due to the conflict in the Middle East [1][7] Pricing Adjustments - The pricing adjustments are necessary to maintain a reliable supply to customers under current market conditions [2][7] - Actions vary by product and region, adapting to local market dynamics, contractual terms, and individual customer requirements [2] - The company will continue to monitor market conditions closely and evolve strategies accordingly [2] Financial Outlook - For fiscal 2026, Ashland expects sales to be between $1.835 billion and $1.905 billion, with adjusted EBITDA projected at $400 million to $420 million [5] - Adjusted EPS is forecasted to show double-digit growth due to operating improvements and portfolio optimization, with free cash flow conversion targeted at approximately 50% of adjusted EBITDA [5] - Capital expenditure is estimated to be around $100 million [5] Stock Performance - ASH stock has declined by 12.3% over the past year, while the industry has seen a smaller decline of 2.3% [4]

BRIGHTSPRING INVESTOR DAY 29 79 145 38 154 188 141 198 63 213 133 18 200 200 200 143 143 143 70 184 218 Agenda March 17, 2026 1 Pharmacy Business Unit Overviews Specialty Pharmacy Infusion Pharmacy Home and Community Pharmacy The BrightSpring Platform Jon Rousseau, President and Chief Executive Officer Benito Fernandez, Chief Commercial Officer Robert Thomson, Chief Growth Officer Christopher Urban, RPh, Chief Operating Officer Rich Denness, President Scott Greenwell, PharmD, President Pharmacy Q&A Provider ...

Core Viewpoint - BofA has raised its price target for Colgate-Palmolive to $105 from $100, maintaining a Buy rating, reflecting increased confidence in the company's business momentum and the execution of its 2030 Strategic Plan [2] Group 1: Financial Performance - Colgate-Palmolive achieved growth in several financial metrics in 2025, including organic sales, net sales, gross profit, base business earnings per share, and free cash flow, despite challenges such as weaker category growth and higher raw material costs [3] - The company reported stronger-than-expected results in Q4 2025, with an optimistic outlook for 2026 marking the start of its new strategic initiatives [2][3] Group 2: Strategic Initiatives - The 2030 strategic framework focuses on five core priorities, including strengthening global brands and accelerating innovation through scientific research [3] - Colgate plans to enhance demand by improving its omnichannel capabilities and increasing the use of digital tools, data, analytics, and AI [4] - A strategic growth and productivity program has been introduced to support organizational changes and fund long-term strategies [4] Group 3: Business Segments - Colgate-Palmolive operates in multiple segments, including Oral Care, Personal Care, Home Care, and Pet Nutrition, positioning itself as a growth-focused business [5]

Financial Data and Key Metrics Changes - In 2025, the company reported organic revenue of $294 million, a 5.3% increase year-over-year, aligning with long-term growth expectations [5] - Adjusted gross margins improved to 38.7%, up 50 basis points from the previous year, primarily due to a favorable product mix [6][26] - The company ended 2025 with $90 million in cash and no debt, reflecting a strengthened balance sheet [6][28] - For Q4 2025, revenue was $88 million, down 11.8% year-over-year, but organic revenue grew 0.7% to $71.3 million [23][24] Business Line Data and Key Metrics Changes - The wipes portfolio saw a consumption growth of 30%, while personal care products grew by 12%, contributing to market share gains [5] - Diaper performance was weaker, with double-digit consumption declines attributed to retail assortment shifts and macroeconomic pressures [12][63] - The company anticipates continued growth in wipes and personal care to offset diaper weaknesses in 2026 [6] Market Data and Key Metrics Changes - The overall diaper category was down 1% in 2025, with consumers shifting towards lower-priced options due to macroeconomic uncertainties [62] - The Honest brand achieved a household penetration of 7.6% by year-end, an increase of 1.7 million households compared to the previous year [8] Company Strategy and Development Direction - The company has exited non-core categories, focusing on wipes, personal care, and diapers, which are seen as areas of competitive advantage [4][19] - The strategy for 2026 includes brand maximization, margin enhancement, and operational discipline, with a target of 4%-6% organic revenue growth [9][30] - The company plans to consolidate its warehouse operations to improve efficiency and reduce costs [19][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver sustainable, profitable growth, citing a strong financial foundation and operational improvements [20][36] - The anticipated challenges in the diaper category for 2026 are acknowledged, with a focus on maintaining a balanced growth portfolio [66][86] Other Important Information - The board has authorized a $25 million share repurchase program, reflecting confidence in the company's strategy and long-term value creation [6][28] - The company expects adjusted EBITDA for 2026 to be in the range of $20 million to $23 million, with a focus on margin expansion [30][34] Q&A Session Summary Question: How should we think about the cadence of organic growth building throughout 2026? - Management indicated confidence in the momentum exiting 2025, expecting continued strong performance in wipes and personal care, supported by new product innovations [40][41] Question: How do you balance buybacks with reinvestment in marketing and innovation? - The company plans to prioritize investment in growth while maintaining liquidity to weather macroeconomic challenges, balancing shareholder returns with reinvestment [45][47] Question: Can you provide insights on growth opportunities and distribution? - Growth is expected to come from a balance of innovation in new products and distribution gains, particularly in the kid personal care aisle [50][51] Question: What adjustments are being made in the diaper category? - Management acknowledged the need for a balanced pricing strategy and value offering in the diaper category, while also focusing on maintaining margin expansion [82][84]

Core Insights - The company experienced a revenue growth of 25.6% in Q4, driven by the successful integration of the Gentiva acquisition and organic expansion in Personal Care [1] Revenue Performance - Personal Care same-store revenue increased by 6.3%, surpassing the typical growth range of 3% to 5%, supported by favorable rates in Texas and stable hiring trends [1] - The Hospice segment saw a significant improvement with 16% organic revenue growth, attributed to operational refinements and a diversified referral base [1] Hiring and Operational Efficiency - The company achieved a hiring rate of 101 caregivers per business day in Q4, maintaining stability despite seasonal holiday slowdowns [1] - Management noted that margin expansion is due to incremental leverage from a higher revenue base and lower acquisition-related expenses compared to the previous year [1] Strategic Focus - The strategic focus remains on creating geographic density, which management believes provides a competitive advantage in serving the full continuum of home-based care [1] - Clinical collaboration is increasing, with over 25% of hospice admissions in overlapping markets now originating from internal Personal Care operations [1]

Core Viewpoint - Colgate-Palmolive Company is positioned as a strong player in the consumer products sector, with a positive outlook supported by Goldman Sachs' "Buy" rating and increased price target [1][5][6] Group 1: Company Performance - Colgate-Palmolive's stock is currently priced at $95.09, reflecting a 1.18% increase following the Consumer Analyst Group of New York Conference 2026 [2] - The stock has shown resilience with a 52-week high of $100.18 and a low of $74.55, indicating stability in its trading range [3] - The current trading range for the day is between $93.39 and $95.10, showcasing the stock's stability [3] Group 2: Market Capitalization and Trading Volume - The company's market capitalization is approximately $76.65 billion, highlighting its significant presence in the consumer goods sector [4][6] - Colgate-Palmolive has a trading volume of 3,562,948 shares, indicating active investor interest and monitoring of its performance [4][6] Group 3: Strategic Initiatives and Investor Sentiment - Goldman Sachs' increased price target from $94 to $100 aligns with Colgate-Palmolive's strategic initiatives aimed at strengthening market position and driving growth [5][6] - The transparency demonstrated at the Consumer Analyst Group of New York Conference is crucial for building investor confidence [2][5]

January inflation as we've been talking about on the consumer level coming in broadly in line with estimates a little bit better the on the headline number uh rising 2.4% on the year. If you strip out volatile food and energy prices the C core number came in at 2 and a.5%. We want to look under the hood as well and look at the categories with the largest increases and decreases.So year-over-year, some of the biggest price increases came in personal care, food away from home, less going to restaurants, and n ...

Core Viewpoint - Addus HomeCare Corporation (NASDAQ:ADUS) is recognized as an overlooked small-cap stock with positive sentiment from Wall Street ahead of its fiscal Q4 2025 earnings report, expected to show approximately $372.87 million in revenue and a GAAP EPS of $1.56 [1] Group 1: Analyst Ratings and Price Targets - Clarke Murphy from Truist Financial initiated coverage on Addus HomeCare with a Buy rating and a price target of $135 [2] - Joanna Gajuk from Bank of America Securities reiterated a Buy rating with a price target of $147 [2] Group 2: Growth Drivers and Strategic Focus - Analysts at Bank of America noted that the positive rating is supported by multiple growth drivers, including expected rate increases in Texas, which align with management's mid-to-high single-digit organic growth target for Personal Care [4] - The company is experiencing hiring momentum, which is anticipated to increase turnover rates, further supporting growth [4] - Addus's strategic focus on Personal Care acquisitions positions it well for future expansion [4] Group 3: Business Segments - Addus HomeCare provides in-home care services across three main segments: Personal Care, Hospice, and Home Health [5]